Seamless Phase II/III Designs in Biomarker-Driven Oncology Trials
Seamless Phase II/III Designs in Biomarker-Driven Oncology Trials Seamless Phase II/III Designs in Biomarker-Driven Oncology Trials Introduction to Seamless Phase II/III Designs Seamless Phase II/III designs in oncology allow the trial to move from an early efficacy signal (Phase II) to confirmatory testing (Phase III) without pausing recruitment. This approach is particularly relevant for biomarker-driven…
Read More “Seamless Phase II/III Designs in Biomarker-Driven Oncology Trials” »